13F HOLDINGS REPORT
Sofinnova Investments, Inc.
Quarter ended Q2 2024 · Filed August 9, 2024 · Accession 0001104659-24-087771
Total Value
$1.92B
Positions
82
Other Managers
0
Confidential Omitted
No
Holdings (82)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | Invesco QQQ TR | IVZ | 400,000 | $191.6M | 9.96% |
| 2 | Natera Inc | NTRA | 1,550,280 | $167.9M | 8.72% |
| 3 | Vera Therapeutics Inc | VERA | 2,793,987 | $101.1M | 5.25% |
| 4 | Ascendis Pharma A/S | ASND | 734,284 | $100.1M | 5.20% |
| 5 | Novo-Nordisk A S | NONOF | 649,541 | $92.7M | 4.82% |
| 6 | Edwards Lifesciences Corp | EW | 724,225 | $66.9M | 3.48% |
| 7 | Stryker Corporation | SYK | 193,084 | $65.7M | 3.41% |
| 8 | AstraZeneca PLC | AZN | 801,417 | $62.5M | 3.25% |
| 9 | Dyne Therapeutics Inc | DYN | 1,625,703 | $57.4M | 2.98% |
| 10 | Align Technology Inc | ALGN | 218,524 | $52.8M | 2.74% |
| 11 | Edwards Lifesciences Corp | EW | 500,000 | $46.2M | 2.40% |
| 12 | Syndax Pharmaceuticals Inc | SNDX | 2,153,669 | $44.2M | 2.30% |
| 13 | Rapport Therapeutics Inc | RAPP | 1,863,327 | $43.3M | 2.25% |
| 14 | Elanco Animal Health Inc | ELAN | 2,864,250 | $41.3M | 2.15% |
| 15 | Abbott Labs | ABLZF | 390,200 | $40.5M | 2.11% |
| 16 | IDEAYA Biosciences Inc | IDYA | 1,151,528 | $40.4M | 2.10% |
| 17 | Intuitive Surgical Inc | ISRG | 87,217 | $38.8M | 2.02% |
| 18 | Alnylam Pharmaceuticals Inc | ALNY | 147,929 | $35.9M | 1.87% |
| 19 | TG Therapeutics Inc | TGTX | 1,861,277 | $33.1M | 1.72% |
| 20 | Arrivent BioPharma Inc | AVBP | 1,696,752 | $31.5M | 1.64% |
| 21 | IDEXX Labs Inc | 45168D104 | 63,862 | $31.1M | 1.62% |
| 22 | Sarepta Therapeutics Inc | SRPT | 195,852 | $30.9M | 1.61% |
| 23 | Y-mAbs Therapeutics Inc | 984241109 | 2,194,278 | $26.5M | 1.38% |
| 24 | Axsome Therapeutics Inc | AXSM | 310,198 | $25.0M | 1.30% |
| 25 | Cogent Biosciences Inc | COGT | 2,773,286 | $23.4M | 1.22% |
| 26 | Spdr Ser Tr | 78464A870 | 250,000 | $23.2M | 1.20% |
| 27 | Soleno Therapeutics Inc | SLNO | 554,359 | $22.6M | 1.18% |
| 28 | Intuitive Surgical Inc | ISRG | 50,000 | $22.2M | 1.16% |
| 29 | Savara Inc | SVRA | 5,358,918 | $21.6M | 1.12% |
| 30 | Celldex Therapeutics Inc | CLDX | 547,707 | $20.3M | 1.05% |
| 31 | Roivant Sciences Ltd | ROIV | 1,868,412 | $19.7M | 1.03% |
| 32 | Establishment Labs Hldgs Inc | ESTA | 429,244 | $19.5M | 1.01% |
| 33 | Inozyme Pharma Inc | 45790W108 | 4,280,308 | $19.1M | 0.99% |
| 34 | Revolution Medicines Inc | RVMDW | 455,099 | $17.7M | 0.92% |
| 35 | Kura Oncology Inc | KURA | 825,243 | $17.0M | 0.88% |
| 36 | Insmed Inc | INSM | 227,747 | $15.3M | 0.79% |
| 37 | Boston Scientific Corp | BSX | 171,080 | $13.2M | 0.68% |
| 38 | Madrigal Pharmaceuticals Inc | MDGL | 44,417 | $12.4M | 0.65% |
| 39 | Insulet Corp | PODD | 60,967 | $12.3M | 0.64% |
| 40 | Alnylam Pharmaceuticals Inc | ALNY | 50,000 | $12.2M | 0.63% |
| 41 | Pharvaris N V | PHVS | 601,534 | $11.3M | 0.59% |
| 42 | Axonics Inc | 05465P101 | 150,490 | $10.1M | 0.53% |
| 43 | Immatics N.V | IMTX | 796,704 | $9.3M | 0.48% |
| 44 | Cabaletta Bio Inc | CABA | 1,220,400 | $9.1M | 0.47% |
| 45 | PepGen Inc | PEPG | 561,128 | $9.0M | 0.47% |
| 46 | Edgewise Therapeutics Inc | EWTX | 475,691 | $8.6M | 0.45% |
| 47 | Immunome Inc | IMNM | 655,680 | $7.9M | 0.41% |
| 48 | Exact Sciences Corp | 30063P105 | 181,828 | $7.7M | 0.40% |
| 49 | Inari Med Inc | 45332Y109 | 155,838 | $7.5M | 0.39% |
| 50 | Dexcom Inc | DXCM | 61,494 | $7.0M | 0.36% |
| 51 | Inhibrx Biosciences Inc | INBX | 463,315 | $6.6M | 0.34% |
| 52 | Achieve Life Sciences Inc | ACHV | 1,388,372 | $6.5M | 0.34% |
| 53 | Waters Corp | 941848103 | 21,804 | $6.3M | 0.33% |
| 54 | Aerovate Therapeutics Inc | 008064107 | 3,758,686 | $6.2M | 0.32% |
| 55 | 4D Molecular Therapeutics Inc | FDMT | 271,155 | $5.7M | 0.30% |
| 56 | Marinus Pharmaceuticals Inc | 56854Q200 | 4,151,576 | $4.9M | 0.25% |
| 57 | Nextcure Inc | NXTC | 2,671,856 | $4.2M | 0.22% |
| 58 | Erasca Inc | ERAS | 1,699,528 | $4.0M | 0.21% |
| 59 | Phibro Animal Health Corp | PAHC | 237,009 | $4.0M | 0.21% |
| 60 | Baxter Intl Inc | 071813109 | 117,769 | $3.9M | 0.20% |
| 61 | Avantor Inc | AVTR | 141,045 | $3.0M | 0.16% |
| 62 | Teleflex Incorporated | TFX | 13,649 | $2.9M | 0.15% |
| 63 | Masimo Corp | MASI | 20,161 | $2.5M | 0.13% |
| 64 | Bolt Biotherapeutics Inc | BOLT | 2,754,437 | $2.1M | 0.11% |
| 65 | Rapport Therapeutics Inc | RAPP | 88,235 | $2.1M | 0.11% |
| 66 | Inspire Med Sys Inc | 457730109 | 10,000 | $1.3M | 0.07% |
| 67 | Disc Medicine Inc | IRON | 29,256 | $1.3M | 0.07% |
| 68 | Perspective Therapeutics Inc | CATX | 132,089 | $1.3M | 0.07% |
| 69 | Zimmer Biomet Holdings Inc | ZBH | 10,630 | $1.2M | 0.06% |
| 70 | LivaNova PLC | LIVN | 20,602 | $1.1M | 0.06% |
| 71 | Immatics N.V | IMTX | 348,731 | $932,855 | 0.05% |
| 72 | Avidity Biosciences Inc | 05370A108 | 21,425 | $875,211 | 0.05% |
| 73 | Ikena Oncology Inc | 45175G108 | 382,616 | $631,316 | 0.03% |
| 74 | Savara Inc | SVRA | 150,000 | $604,500 | 0.03% |
| 75 | Amylyx Pharmaceuticals Inc | AMLX | 300,000 | $570,000 | 0.03% |
| 76 | Amylyx Pharmaceuticals Inc | AMLX | 299,691 | $569,413 | 0.03% |
| 77 | Astria Therapeutics Inc | 04635X102 | 60,692 | $552,297 | 0.03% |
| 78 | PDS Biotechnology Corp | PDSB | 142,635 | $417,921 | 0.02% |
| 79 | Pulmonx Corp | LUNG | 60,246 | $381,960 | 0.02% |
| 80 | Kyverna Therapeutics Inc | KYTX | 47,850 | $358,875 | 0.02% |
| 81 | Structure Therapeutics Inc | GPCR | 8,915 | $350,092 | 0.02% |
| 82 | Marinus Pharmaceuticals Inc | 56854Q200 | 104,700 | $122,499 | 0.01% |